Category

Daily Briefs

Daily Brief Health Care: Saint Bella, QuidelOrtho , Roche Holding , Shield Therapeutics, FibroBiologics, OSE Immuno, Bangkok Dusit Medical Services and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Saint Bella Pre-IPO: Rapid Growth but Facing Birth-Rate Headwinds
  • QuidelOrtho Corporation: Its Diverse Revenue Streams Surge – Discover the Lab Innovations Powering Growth! – Major Drivers
  • Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
  • Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
  • FBLG: On Target to Initiate Phase 1/2 Trial in 2025
  • OSE Immunotherapeutics – Full Lusvertikimab results reflect potential in UC
  • Bangkok Dusit Medical Services (BDMS TB): Both Thai and Foreign Patient Drive Growth, Margins Expand


Saint Bella Pre-IPO: Rapid Growth but Facing Birth-Rate Headwinds

By Nicholas Tan

  • Saint Bella (SAINT HK)  is looking to raise up to US$200m in its upcoming Hong Kong IPO.
  • It operates the second largest and fastest growing postpartum care and recovery service in China, as per Frost & Sullivan. It operates an extensive network of 59 premium postpartum centers.
  • In this note, we look at the firm’s past performance.

QuidelOrtho Corporation: Its Diverse Revenue Streams Surge – Discover the Lab Innovations Powering Growth! – Major Drivers

By Baptista Research

  • QuidelOrtho’s third quarter 2024 financial results reveal a mixed performance, characterized by challenges and opportunities that investors should carefully weigh.
  • The reported revenue for the quarter stood at $727 million, a roughly 2% decline from the previous year, influenced by a decrease in COVID-19 and flu-related revenues compared to the prior year.
  • The company’s adjusted EBITDA was $171 million, translating to an adjusted EBITDA margin of 23.5%, showing an improvement of 80 basis points over the previous year, primarily due to implemented cost-saving measures.

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

By In Good Company with Nicolai Tangen

  • Nicola Tangent and Thomas Schnecker discuss the success and innovation of Roche, a leading healthcare company.
  • Schnecker highlights the importance of understanding the genome to drive innovation in cancer treatment.
  • The conversation delves into the impact of pricing, leadership, and the company’s long-term vision and commitment to patient outcomes.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven

By Hardman & Co

  • Shield is a commercial-stage pharma company delivering specialty products that address the needs of patients with iron deficiency (ID).
  • Since its July 2021 US launch, Shield and Viatris have increased physician awareness of the differentiating characteristics of ACCRUFeR® as an oral ID drug, in order to generate sales traction.
  • The 3Q’24 trading update reiterated the interim statement dialog: sales continue to progress, while costs are being actively managed.

FBLG: On Target to Initiate Phase 1/2 Trial in 2025

By Zacks Small Cap Research

  • On November 12, 2024, FibroBiologics, Inc. (FBLG) announced financial results for the third quarter of 2024 and provided a business update.
  • The company is continuing preparations for a Phase 1/2 clinical trial in Australia to test its fibroblast-based spheroid product as a therapy for diabetic foot ulcers.
  • We anticipate the trial initiating in the second quarter of 2025 and completing by the end of 2025.

OSE Immunotherapeutics – Full Lusvertikimab results reflect potential in UC

By Edison Investment Research

OSE Immunotherapeutics’ final analysis of the CoTikiS trial in ulcerative colitis (UC) confirmed that Lusvertikimab met the primary endpoint with statistical significance, highlighting its potential to offer a clinically meaningful solution for the condition. In our view, this marks a positive step forward for the candidate, which, to our knowledge, has a unique mechanism of action to address chronic inflammatory and autoimmune diseases. We believe that OSE plans to advance this programme to the next stages of development (Phase IIb or Phase III) once a partner is onboard. Based on the encouraging full results, we have increased our probability of success for Lusvertikimab in UC to 35% (from 17%), resulting in a valuation upgrade for OSE to €541.2m or €24.8/share (from €465.7m or €21.3/share previously).


Bangkok Dusit Medical Services (BDMS TB): Both Thai and Foreign Patient Drive Growth, Margins Expand

By Tina Banerjee

  • Bangkok Dusit Medical Services (BDMS TB) posted 6% rise in revenue from hospital operations in 3Q24 as both International and Thai patients revenue reported growth of 8% and 6%, respectively.
  • EBITDA grew at 8% YoY to THB7.1B, due to cost control while net profit also rose 9% YoY to THB4.2B on lower interest cost.
  • BDMS opened Phuket Cancer Center in October 2024 which will help expand cancer patient coverage in Southern part of Thailand.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: FineToday Pre-IPO – The Positives – Established Brands Across Multiple Regions and more

By | Daily Briefs, ECM

In today’s briefing:

  • FineToday Pre-IPO – The Positives – Established Brands Across Multiple Regions
  • Zinka Logistics IPO Trading – Subdued Demand; Lags Recent Listings
  • CiDi IPO Valuation Analysis: High Valuation Is Warranted Due To Unicorn Status/Hyper Growth Profile
  • Pre-IPO Mokingran Jewellery Group (PHIP Updates) – Some Points Worth the Attention


FineToday Pre-IPO – The Positives – Established Brands Across Multiple Regions

By Sumeet Singh

  • CVC Capital is aiming to raise over US$500m, via selling some of its stake in FineToday Holdings Co Ltd (289A JP) in Japan.
  • FineToday (FT) is a beauty and personal care company in Asia offering a range of products, including hair care, skin care and body care products.
  • In this note, we talk about the positive aspects of the deal.

Zinka Logistics IPO Trading – Subdued Demand; Lags Recent Listings

By Akshat Shah

  • Blackbuck (1355652D IN)  raised about US$130m in its India IPO.
  • Zinka Logistics (Blackbuck) is India’s largest digital platform for truck operators (in terms of number of users), with 963,345 truck operators transacting on its platform in FY24, as per Redseer.
  • We have looked at the company’s past performance and valuations in our earlier notes. In this note, we talk about the trading dynamics.

CiDi IPO Valuation Analysis: High Valuation Is Warranted Due To Unicorn Status/Hyper Growth Profile

By Andrei Zakharov

  • Changsha Intelligent Driving Institute, more commonly known as CiDi, filed for an IPO in Hong Kong. The company was valued at ~RMB9B in its last private funding round.
  • CiDi was backed by HongShan Capital, Xinding Capital, Founder Hesheng Investment, Legend Holdings, Baidu Venture, and Lens Technology, among others.  
  • The terms of the IPO were not disclosed. CiDi is a category winner that is addressing a large TAM (~$10B by 2030) with room for hyper growth for years.

Pre-IPO Mokingran Jewellery Group (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • The skyrocketing gold prices have driven up the prices of gold jewelry, but actually dampen the enthusiasm of many people to buy gold jewelry, which will directly affect MOKINGRAN’s performance.
  • MOKINGRAN’s prediction of gold price is incorrect. For an industry veteran, MOKINGRAN shouldn’t make such mistakes. The error in the judgment of important raw material trends is worth investors’ vigilance.
  • We think that valuation of MOKINGRAN should be lower than that of Lao Feng Xiang (600612 CH)/Chow Tai Seng Jewellery (002867 CH)/Chow Tai Fook Jewellery (1929 HK) and industry average.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | Nvidia Falls 1% Post-Earnings and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | Nvidia Falls 1% Post-Earnings
  • SEBI Proposes Sweeping Changes to SME IPO Framework
  • Japan Morning Connection: Will SPE Sentiment Begin to Rise?
  • China & HK Strategy: Names to Watch for Market Value Management
  • For Its WFE Q324 Season Finale, AMAT Returns ASML’s Favour & Sinks Semis Yet Again
  • SEBI Study: Royalty Payments by Listed Companies to Related Parties


Ohayo Japan | Nvidia Falls 1% Post-Earnings

By Mark Chadwick

  • The S&P 500 and Nasdaq 100 ended little changed, recovering from earlier losses following Ukraine’s missile strikes on Russia
  • Nvidia delivered stronger-than-expected third-quarter results, with EPS of $0.81 on $35.1 billion in revenue
  • Rapidus: The Japanese government plans to invest 200 billion yen in Rapidus to support cutting-edge chip production, with total funding needs of 5 trillion yen

SEBI Proposes Sweeping Changes to SME IPO Framework

By Nimish Maheshwari

  • SEBI is proposing significant changes to the SME IPO framework, including increasing the minimum application size, restricting the OFS component, and introducing a monitoring agency.
  • SEBI proposes changes in  the allocation methodology for non-institutional investors, increasing the minimum number of allottees in an SME public issue, and introducing a mandatory profitability benchmark for companies
  • The proposed changes aim to address concerns regarding investor protection and market integrity in the SME segment. 

Japan Morning Connection: Will SPE Sentiment Begin to Rise?

By Andrew Jackson

  • NVDA slight beat not enough to appease market, but strong AI outlook is positive.
  • Timing may be right to look at names like TEL and Disco again now NVDA de-risked
  • Qualcomm down after its IR day and concerns its future focus on Autos and IoT wont replace Apple.

China & HK Strategy: Names to Watch for Market Value Management

By Osbert Tang, CFA


For Its WFE Q324 Season Finale, AMAT Returns ASML’s Favour & Sinks Semis Yet Again

By William Keating

  • Revenues of $7.05 billion were marginally higher than midpoint of $6.93 billion, up 4% QoQ and up 5% YoY.  Guided current quarter at $7.15 billion +1.5% QoQ , +10.5% YoY
  • Most WFE share prices have retreated to early 2022 levels, matching with when annual revenues first exceeded the $100 billion level
  • After a 44% growth spurt in 2021, we have had three years with mostly no growth. We expect the same in 2025. Invest accordingly

SEBI Study: Royalty Payments by Listed Companies to Related Parties

By Nimish Maheshwari

  • SEBI’s study reveals rising royalty payments by listed companies to related parties, highlighting doubling of payments to Rs. 10,779 crore in FY23 over a decade.
  • 25% of firms pay royalties exceeding 20% of net profits, raising concerns about transparency, governance, and shareholder returns versus royalty prioritization.
  • SEBI’s findings stress the urgency for enhanced royalty disclosures, policy revisions, and better scrutiny to protect minority shareholders and corporate governance standards.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: [Alibaba (BABA US and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • [Alibaba (BABA US, BUY, TP US$120) Earnings Review]: Progress Made, Better Times Ahead
  • Tesla’s Big Bet: Why Trump’s Autonomous Push Could Supercharge Their Future!
  • KS / Kuaishou (1024 HK): 3Q24, Ad and E-Commerce Strong, Margins Improved
  • Nvidia: Maybe a Few Short-Term Concerns but Blackwell Looks like a Step Function Upwards
  • Qualcomm Investor Day: Based on Management Forecasts, Best Case 13% Operating Profit Cagr to FY29
  • Honda Faces Profit Crunch: Rising Costs vs. Ambitious EV Plans! – Major Drivers
  • Enviro Infra Engineers Limited IPO Analysis
  • 2025 High Conviction: Freee KK – Becoming Free From Losses; Significant Upside
  • [NetEase, Inc. (NTES US, BUY, TP US$118) TP Change]: Growth Rebounds Ahead from Both PC and Mobile
  • We unpack 2 North American Deals


[Alibaba (BABA US, BUY, TP US$120) Earnings Review]: Progress Made, Better Times Ahead

By Ying Pan

  • BABA reported CY3Q24 top line, adjusted EBITA and non-GAAP net profit (1.0%), (1.6%) and in-line vs. consensus. 
  • CMR improved amid monetization changes that narrowed the growth gap with GMV, but also eliminated some low-single profit sellers from its GMV. 
  • Cloud and overseas e-commerce revenue also saw good growth and improved profitability. All of BABA’s key businesses are sputtering to life while macro tailwinds are also favorable. 

Tesla’s Big Bet: Why Trump’s Autonomous Push Could Supercharge Their Future!

By Baptista Research

  • During Tesla’s third quarter of 2024 financial report, several key points emerged that provide an overview of the company’s performance and strategic direction.
  • One of the prominent highlights was Tesla’s achievement of record deliveries in a market experiencing overall industry declines.
  • This emphasizes Tesla’s ability to navigate a challenging automotive landscape, an important consideration for investors assessing the company’s resilience and market positioning.

KS / Kuaishou (1024 HK): 3Q24, Ad and E-Commerce Strong, Margins Improved

By Ming Lu

  • Both online marketing and “other revenues” grew strongly in 3Q24.
  • Both the gross margin and the operating margin improved over the same period last year.
  • We believe total revenue will accelerate when live streaming is not significant and margins will rise when e-commerce makes profit.

Nvidia: Maybe a Few Short-Term Concerns but Blackwell Looks like a Step Function Upwards

By Nicolas Baratte

  • 3Q25 (Oct-25) 5% above Consensus, Hopper growing incl H200, no Blackwell revenue. 4Q25 (Jan-25) guidance inline with Consensus but Nvidia has beat guidance for 8 quarters.
  • Jan-25: Blackwell revenue “several billion dollars”. Supply keeps to increase but supply constraints. GM will moderate to low-70% during Blackwell ramp due  but will stabilize at mid-70%.
  • The stock is not expensive, trading at its average multiples since 2019: 51x trailing EPS, 34x forward EPS. These multiples are high in an absolute sense, but average for NVDA.

Qualcomm Investor Day: Based on Management Forecasts, Best Case 13% Operating Profit Cagr to FY29

By Nicolas Baratte

  • QCOM estimates ~5% Android revenues growth Cagr to FY29, Automotive 22%, IoT 21%. If QCOM keeps Apple business, revenue Cagr will be 9% to FY29. If QCOM loses it: 6%.
  • Mngt forecasts high Opex control, target at 22% of revenue, which looks aggressive. Opex reached 31% in FY23-24 . At 22% Opex, Operating Profit would grow ~13% Cagr to FY29.
  • Android growth looks low, Opex control demanding. As such, we could conclude that 10% Operating Profit Cagr is more likely than 13%. Even with lower growth, the stock is cheap. 

Honda Faces Profit Crunch: Rising Costs vs. Ambitious EV Plans! – Major Drivers

By Baptista Research

  • Honda Motor Co., Ltd.’s financial results for the first quarter of the fiscal year 2025 offer a complex picture of both achievements and challenges.
  • The company reported its highest-ever quarterly operating profit of JPY 484.7 billion, marking a significant year-on-year increase by JPY 90.2 billion.
  • This improvement was largely driven by increased unit sales in the motorcycle business in India and Brazil, as well as robust sales of hybrid automobile models in Japan and the United States.

Enviro Infra Engineers Limited IPO Analysis

By Nimish Maheshwari

  • The company is in the business of designing, construction, operation and maintenance of water and wastewater treatment plants and supply schemes with all related services.
  • It has an order book worth Rs. 1906+ cr. as of June 30, 2024 and 750Cr+ of operation & maintenance order book in their hand.
  • Company has in-house capability to build and design water plants which enhance the margins of the company vs its peers. 

2025 High Conviction: Freee KK – Becoming Free From Losses; Significant Upside

By Shifara Samsudeen, ACMA, CGMA

  • Freee KK (4478 JP) offers cloud-based online accounting and HR/Payroll software to small and medium businesses (SMBs) in Japan. The company operates a subscription-based revenue model.
  • Freee reported its first-ever profits recently and we expect continued improvement in freee’s profitability driven by its strong business model vs MF whose business model has started to breakdown.
  • Freee’s current valuation multiples are cheap and there is significant upside to the current share price, hence we recommend making an entry.

[NetEase, Inc. (NTES US, BUY, TP US$118) TP Change]: Growth Rebounds Ahead from Both PC and Mobile

By Ying Pan

  • NetEase reported C3Q24 revenue, GAAP operating profit and GAAP net income in line, (3.6%) and (5.3%) vs. our estimates, and in line, (4.4%) and (5.0%) vs. consensus. 
  • Mobile game revenue decline is less a concern due to imminent pipeline launches, but PC game’s significantly beat is a positive surprise. 
  • We raised the TP to US$118 for the better outlook of new game launches.

We unpack 2 North American Deals

By Money of Mine

  • Orla Mining acquired by Newmont in $850 million deal with production assets in Mexico and development assets in the United States
  • Orla Mining has strong shareholder support including PL mining 10% of the company, Fairfax, Newmont, and Agnico
  • Muscle White mine in Canada has a 6.23 grams per tonne reserve grade with a reserve life until 2030, operating at 1 million tonnes per annum with high recoveries and FIFO operated mine with camp upgrades in progress

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Health and Happiness (H&H), Yinson Production, Xiaomi Corp, ReNew Energy
  • In the US, October housing starts declined 3.1% m-o-m to an annualised 1.31 mn units (-1.5% e / -1.9% revised p), the slowest pace in three months as builders put off projects in the wake of hurricanes Helene and Milton.
  • Meanwhile, October building permits (a proxy for future construction) eased 0.6% m-o-m to an annualised 1.42 mn units.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: KT&G Corporation and more

By | Daily Briefs, South Korea

In today’s briefing:

  • ₩200B Gov-Run Value-Up Fund Starts Buying Tomorrow, with Another ₩300B Set for Year-End


₩200B Gov-Run Value-Up Fund Starts Buying Tomorrow, with Another ₩300B Set for Year-End

By Sanghyun Park

  • The larger-than-expected Value-Up fund will drive passive flows surpassing the KRX 300 in both size and speed.
  • Value-Up ETFs’ AUM is ₩636.5B, with retail dominating. Major institutions, like pensions, are on standby, but passive flows could hit ₩1.5T post-Dec 20 rebalancing.
  • Single-Stock setups may not fit, but for alpha-seeking Value-Up strategies, focus on names with higher passive impact from the boosted AUM.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Finfra and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Finfra Secures US$2.5M to Power Indonesia’s Lending Ecosystem in New Partnership with Tyme Group|E27


Finfra Secures US$2.5M to Power Indonesia’s Lending Ecosystem in New Partnership with Tyme Group|E27

By e27

  • Indonesia-based lending infrastructure firm Finfra has received US$2.5 million in a funding round led by Cento Ventures.
  • Accion Venture Lab, Z Venture Capital, Matiss Ansviesulis (founder of Avafin), and existing investors also participated.
  • The company will use the new funds to expand onboarding capabilities for customers and target profitability. Additionally, Finfra plans to enhance its data analytics, scoring, and risk assessment products.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Private Markets: BuzzAR lands US$1.16M in funding to boost Saudi tourism with AI-driven travel companion | e27 and more

By | Daily Briefs, Private Markets

In today’s briefing:

  • BuzzAR lands US$1.16M in funding to boost Saudi tourism with AI-driven travel companion | e27
  • Finfra Secures US$2.5M to Power Indonesia’s Lending Ecosystem in New Partnership with Tyme Group|E27


BuzzAR lands US$1.16M in funding to boost Saudi tourism with AI-driven travel companion | e27

By e27

  • Singapore-based mixed reality and AI company BuzzAR has secured US$1.16 million in funding from the HSBC New Economy Fund.
  • The firm is using the money raised to expand its presence in the Middle East and North Africa (MENA) region, particularly Saudi Arabia, where it has partnered with the tourism department.
  • Founded in 2018 by Bell Beh and Ken Lim, BuzzAR specialises in experiential engagements that bridge the gap between offline and online spaces for its clients.

Finfra Secures US$2.5M to Power Indonesia’s Lending Ecosystem in New Partnership with Tyme Group|E27

By e27

  • Indonesia-based lending infrastructure firm Finfra has received US$2.5 million in a funding round led by Cento Ventures.
  • Accion Venture Lab, Z Venture Capital, Matiss Ansviesulis (founder of Avafin), and existing investors also participated.
  • The company will use the new funds to expand onboarding capabilities for customers and target profitability. Additionally, Finfra plans to enhance its data analytics, scoring, and risk assessment products.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Trump Watch: Possible U-Turn on Tariffs? and more

By | Daily Briefs, Macro

In today’s briefing:

  • Trump Watch: Possible U-Turn on Tariffs?
  • Overseas Equity ETFs Surpass Domestic Equity ETFs For the First Time in 17 Years
  • China Economics: Don’t Celebrate October’s Uptick Just Yet
  • [US Nat Gas Options Weekly 2024/46] Henry Hub Prices Increased as Demand Outlook Improved
  • [US Crude Oil Options Weekly 2024/46] WTI Dropped Amid Weak Demand Outlook and Strong Dollar
  • UK Inflation Flies Cuts To 2025
  • Ivory Coast Lists Four Point Strategy To Place Its Rubber Globally
  • CX Daily: China Is Making Sure Its Low-Altitude Economy is Ready for Takeoff
  • Actinver Research – Macro Daily: Public Finance 2025
  • Actinver Research – Macro Daily: Inflation 1h-Nov


Trump Watch: Possible U-Turn on Tariffs?

By Andreas Steno

  • Our Geopolitical team is wrapping up an analysis on the escalating Ukraine-Russia conflict.
  • In the meantime, here’s a piece we believe markets might not yet be fully tuned into:With Donald Trump and Elon Musk seemingly forming a close alliance, their influence on trade and economic policies has become a hot topic.
  • Notably, Vivek Ramaswamy and Musk have thrown their support behind Javier Milei’s economic strategy in Argentina, which includes radical measures such as aggressive spending cuts and a commitment to reducing trade barriers.

Overseas Equity ETFs Surpass Domestic Equity ETFs For the First Time in 17 Years

By Douglas Kim

  • One of the biggest trends impacting the fund flow in Korea this year has been the huge capital inflow into overseas equity ETFs. 
  • The net asset value of the listed ETFs in Korea investing in overseas stocks surpassed the ETFs investing in domestic stocks for the first time in 17 years.
  • The ETFs that invest in overseas stocks were 35.8 trillion won on 12 November 2024, up 111% from 12 January 2024.

China Economics: Don’t Celebrate October’s Uptick Just Yet

By Manu Bhaskaran

  • The tentative green shoots in consumer and business demand seen in the latest data are likely due to one-off factors.  A sustained recovery is still some distance away. 
  • The fundamental underpinnings of domestic demand remain shaky, given continued weakness in the labour and property markets and external uncertainties. 
  • Moreover, with the trade war likely to be escalated by the next US administration, the Chinese economy may suffer material damage from a more hostile external environment. 

[US Nat Gas Options Weekly 2024/46] Henry Hub Prices Increased as Demand Outlook Improved

By Suhas Reddy

  • US natural gas prices rose 5.77% for the week ending 15/Nov, buoyed by forecasts of cooler weather, rising US LNG exports, and declining production.
  • Henry Hub Put/Call volume ratio sharply rose to 1.08 from 0.65 (08/Nov) the previous week as put volumes rose by 53.5% WoW, while call volumes fell by 7.0%. 
  • Call OI increased for December, January, February, and March expirations, while put OI was substantial for November, April, May, June, and July contracts.

[US Crude Oil Options Weekly 2024/46] WTI Dropped Amid Weak Demand Outlook and Strong Dollar

By Suhas Reddy

  • WTI futures dropped 4.77% for the week ending 15/Nov, pressured by a bleak demand outlook, a rising dollar, and weak economic data from China.
  • WTI options Put/Call volume ratio rose to 1.00 from 0.66 (08/Nov) last week, as call volume dropped by 57.3% WoW and put volume fell by 35.4%.  
  • WTI OI PCR climbed to 0.86 from 0.77 (08/Nov) last week. Call OI fell by 37.9% WoW, while put OI fell by 29.9%.

UK Inflation Flies Cuts To 2025

By Phil Rush

  • A surprising airfare rebound extended CPI inflation’s energised rise to 2.3%. Its higher weighting in core and services measures compounded the upside surprise there.
  • Underlying inflation also strengthened on other measures, like the median, and looks inconsistent with a sustainable return to the inflation target.
  • We still expect inflation to trend above the target in 2025 on excessive unit labour cost pressures. The BoE can remain gradual in its easing cycle, skipping a cut in December.

Ivory Coast Lists Four Point Strategy To Place Its Rubber Globally

By Farah Miller

  • Rubber Meet spots Risk Center, EUDR, industry academy as priorities
  • RAOT delegation holds talks with APROMAC top brass
  • Ivory Coast cup lump exports ban to stay, says APROMAC official

CX Daily: China Is Making Sure Its Low-Altitude Economy is Ready for Takeoff

By Caixin Global

  • Airspace / China is making sure its low-altitude economy is ready for takeoff China is looking to the skies for future growth as it nurtures its nascent low-altitude economy with efforts to launch pilot programs for new aviation services.
  • The National Development and Reform Commission (NDRC), the country’s top economic planner, is to create a Low-Altitude Economy Department to oversee the sector as it takes off, according to Chen Zhijie, director of the State Key Laboratory of Air Traffic Management System and Technology.
  • At the same time, the central government is drawing up detailed industry guidelines to establish a regulatory framework for the sector, Chen said at a Monday forum.

Actinver Research – Macro Daily: Public Finance 2025

By Actinver

  • The 2025 budget sends the right signals to the market by reinstating financial discipline.
  • However, given the macroeconomic assumptions, the global economic environment, and the limited flexibility in spending, there is little room for deviations.
  • The federal government presented the 2025 Economic Package, in which the broadest measure of debt (Public Sector Financial Requirements, RFSP) is planned to decrease from 5.9% of GDP this year to 3.9% in 2025. 

Actinver Research – Macro Daily: Inflation 1h-Nov

By Actinver

  • For the first half of November, we forecast headline inflation at 0.40% bw, below the historical average due to the early discount season of “El Buen Fin”.
  • This would bring inflation to 4.59% YoY.
  • Our estimate of 0.40% bw is below the historical average of 0.54% bw for this period.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Seven & I Holdings (3382 JP): Evaluating the Potential MBO and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Seven & I Holdings (3382 JP): Evaluating the Potential MBO
  • Amcor Ltd/Berry Global: Packing Them In
  • [JAPAN ACTIVISM] Exedy (7278) – Immediate Results Reaction Was a Damp Squib, But Climbing Now
  • Even in Japan, Significant Growth Potential for Seven Eleven and Other CVS
  • Kadokawa (9468 JP): Take Profits as a Sony Privatisation Rumours Surface
  • Quiddity Leaderboard HSIII: ~US$160mn One-Way Flows in Dec 24; 3 ADDs/DELs in Mar 25 Likely
  • Quiddity Leaderboard Hang Seng Biotech Dec 24: Positive Flows for Beigene and Innovent Biologics
  • NIFTY200 Momentum30 Index Rebalance Preview: More Changes with New F&O Stocks
  • ₩200B Gov-Run Value-Up Fund Starts Buying Tomorrow, with Another ₩300B Set for Year-End
  • CM Hi-Tech (2115 HK): 12th December Shareholder Vote


Seven & I Holdings (3382 JP): Evaluating the Potential MBO

By Arun George

  • Seven & I Holdings (3382 JP) did not dispute the NHK article’s claims that the founding family aims to raise buyout funds by the end of the fiscal year.
  • Since 13 November, there have been conflicting press reports on the MBO offer price. The NHK article’s implied offer price of JPY3,082 seems the most credible. 
  • The MBO’s aggressive completion timeline pressures Alimentation Couche-Tard (ATD CN) to respond by either overbidding, working with the founding family at the back-end or walking away.

Amcor Ltd/Berry Global: Packing Them In

By David Blennerhassett

  • Packing giants Amcor Limited (AMCR US/AMC AU) and Berry Global Group (BERY US) announced they will combine in an all-stock transaction, with a ~63%/37% ownership split (respectively) in the MergeCo.
  • Amcor will issue 7.25 Amcor shares for each Berry share, for a US$73.59/share implied price. US$650mn of benefits from identified cost, growth and financial synergies by end of third year.
  • Closing, subject to shareholder and reg approvals, is targeted in the middle of 2025. The transaction has been unanimously approved by the boards of both Amcor and Berry.

[JAPAN ACTIVISM] Exedy (7278) – Immediate Results Reaction Was a Damp Squib, But Climbing Now

By Travis Lundy

  • I wrote last when Exedy was at ¥3,900 and had just announced, good earnings, a sharp div hike, and a huge buyback. The stock reacted well, but not THAT well.
  • Murakami-San had indeed lifted his stake, and the stock is now climbing again. Presumably, the company is in the market buying. At this price, it depends on what Murakami-san does.
  • Fat div. Lots of volume to buy in the next several months, but the big story is future measures.

Even in Japan, Significant Growth Potential for Seven Eleven and Other CVS

By Michael Causton

  • Seven Eleven’s future usually gets outlined as: Japan ex-growth and only growth is overseas. This is wrong. While the CVS sector is saturated, Seven Eleven itself has not reached saturation.
  • There are major areas of growth, both territorially and new offshoot businesses.  Seven is already 32% more efficient than Lawson but more to come.
  • Here we take a deep dive into the state of CVS retailing in Japan and how Seven Eleven does, and will, fit into this – and how it will grow.

Kadokawa (9468 JP): Take Profits as a Sony Privatisation Rumours Surface

By Arun George

  • Kadokawa Dwango (9468 JP) shares rose 16% after Reuters reported that Sony Corp (6758 JP) is in talks to acquire it. Kadokawa confirmed an initial letter of intent. 
  • The privatisation interest is unsurprising as Kadokawa’s publishing arm, acclaimed intellectual properties, and positioning in the anime industry would be attractive to Sony.
  • The upside is limited as the last close reflects a significant takeover premium. There is a risk if a binding proposal emerges, it could be takeunder like Bain/T-Gaia.

Quiddity Leaderboard HSIII: ~US$160mn One-Way Flows in Dec 24; 3 ADDs/DELs in Mar 25 Likely

By Janaghan Jeyakumar, CFA

  • The Hang Seng Internet & IT (HSIII) index represents the top 30 stocks related to internet and information technology businesses listed in Hong Kong (HKEX).
  • The indicative weights for the December 2024 index rebal event will be announced later this week on Friday 22nd November 2024.
  • In this insight, we take a look at our updated flow estimates for December 2024. Separately, we have also presented our latest March 2025 index review predictions.

Quiddity Leaderboard Hang Seng Biotech Dec 24: Positive Flows for Beigene and Innovent Biologics

By Janaghan Jeyakumar, CFA

  • The HS HK-Listed Biotech Index (“Hang Seng Biotech Index”) represents the 50 largest biotech companies listed in Hong Kong (HKEX).
  • The official index changes and indicative weights for the December 2024 index rebal event will be announced on Friday 22nd November 2024.
  • In this insight, we take a look at our updated flow expectations.

NIFTY200 Momentum30 Index Rebalance Preview: More Changes with New F&O Stocks

By Brian Freitas

  • There could be 17 changes for the Nifty200 Momentum 30 Index that will be implemented at the close on 30 December. Some changes from earlier following 45 new F&O stocks.
  • If all changes are on expected lines, one-way turnover is estimated at 61.5% and that will result in a one-way trade of INR 63.4bn (US$752m).
  • The potential inclusions to the index have outperformed the potential deletions since the start of June. This trend could continue for a couple of weeks till the changes are announced.

₩200B Gov-Run Value-Up Fund Starts Buying Tomorrow, with Another ₩300B Set for Year-End

By Sanghyun Park

  • The larger-than-expected Value-Up fund will drive passive flows surpassing the KRX 300 in both size and speed.
  • Value-Up ETFs’ AUM is ₩636.5B, with retail dominating. Major institutions, like pensions, are on standby, but passive flows could hit ₩1.5T post-Dec 20 rebalancing.
  • Single-Stock setups may not fit, but for alpha-seeking Value-Up strategies, focus on names with higher passive impact from the boosted AUM.

CM Hi-Tech (2115 HK): 12th December Shareholder Vote

By David Blennerhassett

  • Back on the 14th October, cleanroom play CM Hi-Tech (2115 HK) announced a pre-conditional Offer by way of a Scheme from MayAir Technology (688376 CH) and CM Hi-Tech’s senior management.
  • The pre-conditional long stop for NDRC, Mofcom and SAFE was 60 days, which appeared highly optimistic. I was wrong, and the pre-cons were secured in a legendary 18 days.
  • The Scheme Doc is now out, with a Court Meeting to be held on the 12 December. Expected payment on the 15 January. The IFA says fair & reasonable.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars